Kadar C-Reactive Protein dan Laju Filtrasi Glomerulus Pasien Diabetes Melitus Tipe 2 Obesitas di RSUD Margono Soekarjo Purwokerto
Main Article Content
Abstract
Background. C-Reactive Protein, which is an acute protein as an inflammation marker, is elevated in Type 2 Diabetes Mellitus (T2DM) with obesity. One of the complications of T2DM is diabetic nephropathy, which the kidney disorder occurs due to the atherosclerosis that would cause renal vasoconstriction and decreased Glomerula Filtration Rate (GFR).
Objectives. To analyze the correlation of CRP level with GFR in patients with T2DM and obesity in RSUD Margono Soekarjo Purwokerto.
Methods. The design of this study is observational analytic with cross sectional approach, carried out on 48 patients T2DM with obesity in Internal Clinic RSUD Margono Soekarjo, aged 35-60 years old. Subjects who use Insulin therapy, antibiotics, anti-inflammatory and diuretic medications, which suffer from kidney disease, liver disease, infection , trauma and dehydration were excluded from the study. Data were analyzed with the Pearson correlation test. Where p < 0,05 indicates a significant correlation. CRP levels were tested with hs-CRP test and GFR calculate with the MDRD formula.
Results. Results of the analysis with the Pearson correlation test between CRP levels and GFR values obtained p = 0,045 and r =
-0,290. There is a significant correlation between CRP levels and GFR, with negative and moderate correlational strength. Conclusion. There is a correlation between CRP levels and GFR in patients with Type 2 Diabetes and obesity in RSUD Margono Soekarjo Purwokerto.
Keywords : C-Reactive Protein (CRP), high sensitivity C-Reactive Protein (hsCRP), Glomerular Filtration Rate (GFR), Type 2 Diabetes with Obesity.
Downloads
Article Details
References
2. Nathan DM dan Delahanthy LM. 2009. Menaklukkan Diabetes. Jakarta: Gramedia, Hal : 7.
3. PERKENI. 2011. Konsensus Pengelolaan dan Pencegahan Diabetes Melitus tipe 2 di Indonesia. Jakarta: PB Perkeni.
4. Dinas Kesehatan Kabupaten Banyumas. 2010.
Profil Kesehatan Kabupaten Banyumas.
5. Ganong, WF. 2003. Buku Ajar Fisiologi Keokdteran Ganong. Edisi 22, Jakarta:EGC.
6. Hadi, H. 2005. Beban Ganda Masalah Gizi dan Implikasinya terhadap Kebijakan Pembangunan Kesehatan Nasional. Pidato Pengukuhan Guru Besar Fakultas Kedokteran Universitas Gadjah
Mada. Yogyakarta.
7. Roesli R, Susalit E, Djafaar J. 2001. Nefropati Diabetik. Dalam: Suyono S, ed. Ilmu Penyakit Dalam Jilid II. Edisi 3. Jakarta. Balai Penerbit FK UI : 356- 65
8. Kabo, P. 2010. Bagaimana Menggunakan obat- obatan kardiovaskular secara rasional. Jakarta : Balai Penerbit Universitas Indonesia.
9. Guyton AC & Hall JE. 2008. Buku Ajar Fisiologi Kedokteran. Jakarta : EGC.
10. Campbell DJ, Somaratne J, Jenskins AJ, Prior DL, Yii M, Kenny JF. 2011. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and myocardiovasculature of men with coronary artery disease. Available at : http://www.cardiab.com/ content/10/1/80. Diakses pada 4 Oktober 2012.
11. Thang SH, Ken W, Naveed S, Kelly JII, Michael EJC, Steven MH. 2002. Analysis of Obesity and Hyperinsulinemia in the Development of Metabolic Syndrome : San Antonio Heart Study. Obesity Research Vol.10 (9) : 923-31.
12. Wild S, Roglic G, Green A, Sicrec R, King H. 2004. Global Prevalence of Diabetes Estimates for the Year 2000 and Projections for 2030. Diabetes Care 27 : 1047-1053.
13. Kemenkes, 2013. Profil kesehatan Indonesia 2013. Jakarta; Depkes RI
14. Shahedi V, Elzadi M, Imanipour V, Seyedhoserni MA. 2011. Association of C Reactive Protein with Insulin Resistance ini Type 2 Diabetic. International Conference on Bioscience, Biochemistry and Bioinformatics, vol 5.
15. Pearson TA, Mensah GA, Alexander RW. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. Jan 28 2003;107(3):499-511.
16. Bhowmick K, Kutty AVM, Shetty HV. 2007. Glycemic Control Modifies The Association Between Microalbuminuria and C-Reactive Protein in Type 2 Diabetes Mellitus. Available at : http://medind.nic.in/ iqf/r07/ i2/iqft07/i2p53.pdf. Diakses pada tanggal 20 Agustus 2013.
17. Kabo, P. 2008. Mengungkap pengobatan penyakit jantung koroner. Jakarta : PT Gramedia Pustaka Utama.
18. Angela YW, Mei W, Jean W, Christopher WL, Siu FL, Philip KT, Joha ES. 2004. Inflammation, Residual Kidney Function, and Cardiac Hypertrophy are Interrelated and Combine Adversely to Enhance Mortality and Cardiovascular Death Risk of Peritoneal Dialysis Patients. Journal of the American Society of Nephrology (15) : 2186-2194.
19. Yeo ES, Hwang JY, Park JE, Choi YJ, Huh KB, Kim WY. 2010. Tumor Necrosis factor (TNF-alpha) and
C-Reactive Protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes. Yonsei Medical Journal 51(4): 519-25.
20. Setianto dan Budi Y. 2007. Hubungan antara C-Reactive Protein dan Microalbuminuria pada sindroma Koroner Akut. Berkala Kesehatan Klinik vol XIII (2) : 89-94.